儿宝健品牌怎么样 申请店铺

我要投票 儿宝健在电蚊香行业中的票数:408 更新时间:2025-08-25
儿宝健是哪个国家的品牌?「儿宝健」是 中山榄菊日化实业有限公司 旗下著名品牌。该品牌发源于广东省中山市,由创始人骆总在1982年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力儿宝健品牌出海!将品牌入驻外推网,定制儿宝健品牌推广信息,可以显著提高儿宝健产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

儿宝健怎么样

榄菊集团旗下儿童蚊香品牌,家用杀虫产品行业标准主要起草单位,知名的蚊香、电热蚊香片、蚊香液等系列儿童护理产品供应商


儿宝健是中山榄菊日化实业有限公司旗下独立的专业驱蚊虫品牌。

中山榄菊日化实业有限公司是集团的核心企业,创建于1982年。凭借专业化生产,公司积聚了雄厚的制造优势,先后在广东中山、江西大余、重庆璧山、安徽明光等地兴建了五大工业园区。

公司一贯注重科技领先,以先进的研发理念和创新的研发体制走产学研一体化道路,与国内外科研机构、国际原材料供应商及高等院校建立了紧密合作关系。目前,公司已在行业领域掌握了诸多核心技术,形成了以家卫杀虫产品系列为核心、洗涤用品系列为发展的产品族群。

秉承“诚信服务”理念,榄菊在中国本土乃至国际市场上精耕细作,凭借独特的深度分销模式,在全国30多个省市、260多座大中城市设立了分公司、市场部、直营部和经销商,掌握了覆盖城乡的市场网络。公司的海外业务已拓展至非洲、中东和东南亚地区的20多个国家。

不畏严寒,其志弥坚,不事张扬,其味溢香,是菊之本性。榄菊人将一如既往地秉承“护卫家居健康,增强顾客满意”的质量方针,全力打造以家庭卫生杀虫制品为核心、家居清洁洗涤用品为发展的制造企业航母,以更丰富、更优质的产品实现对消费者永恒的承诺!


The brand of children's mosquito repellent incense of Lanju group, the main drafting unit of the industry standard of household insecticide products, the well-known supplier of series of children's care products such as mosquito repellent incense, electrothermal mosquito repellent incense, mosquito repellent liquid, etc. Er Baojian is an independent professional mosquito repellent brand of Zhongshan Lanju daily Chemical Industry Co., Ltd. Zhongshan Lanju Daily Chemical Industry Co., Ltd. is the core enterprise of the group, founded in 1982. With professional production, the company has accumulated strong manufacturing advantages, and has built five industrial parks in Zhongshan, Jiangxi Dayu, Chongqing Bishan, Anhui Mingguang and other places. The company has always attached great importance to leading science and technology. With advanced R & D concept and innovative R & D system, it has taken the road of integration of production, teaching and research, and has established close cooperation with domestic and foreign scientific research institutions, international raw material suppliers and colleges and universities. At present, the company has mastered many core technologies in the industry field, forming a product group with the family health insecticidal product series as the core and the washing product series as the development. Adhering to the concept of "honest service", with its unique in-depth distribution mode, Lanju has set up branches, marketing departments, direct sales departments and distributors in more than 30 provinces and cities and 260 large and medium-sized cities, and has mastered the market network covering urban and rural areas. The company's overseas business has expanded to more than 20 countries in Africa, the Middle East and Southeast Asia. It's the nature of chrysanthemum to be fearless of the cold, strong in ambition, not to be publicized, and fragrant in taste. Lanju people will, as always, adhere to the quality policy of "protecting household health and enhancing customer satisfaction", strive to build a manufacturing enterprise aircraft carrier with household sanitary and insecticidal products as the core and household cleaning and washing products as the development, and realize the eternal commitment to consumers with richer and higher quality products!

本文链接: https://brand.waitui.com/e0fe1b3cc.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

格林美:筹划发行H股股票并在香港联交所上市

36氪获悉,格林美发布公告,经充分研究论证,董事会同意公司发行H股股票并在香港联合交易所有限公司(简称“香港联交所”)主板挂牌上市。公司将充分考虑现有股东的利益和境内外资本市场的情况,在股东会决议有效期内(即经公司股东会审议通过之日起24个月或同意延长的其他期限)选择适当的时机和发行窗口完成本次发行上市。截至目前,公司正积极与相关中介机构就本次发行上市的相关工作进行商讨,除本次董事会、监事会审议通过的相关议案外,其他关于本次发行上市的具体细节尚未最终确定。

42分钟前

中信证券:预计未来中国前列腺癌RDC诊疗市场将超100亿元

36氪获悉,中信证券研报表示,创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求,改变前列腺癌诊疗范式,实现诊疗一体化,提高患者依从性和生存期。目前中国尚无任何RDC上市,市场呈现蓝海状态,海外前列腺癌RDC诊疗产品在2021年上市,2024年市场已接近30亿美元,充分验证了其巨大的商业价值。中信证券认为中国有望复刻海外前列腺癌RDC诊疗市场发展路径,预计未来中国前列腺癌RDC诊疗市场将超100亿元,市场呈现高速增长状态。该行业关键点为核素、配体分子形态、生产配送能力,建议关注在上述条件具有优势的公司。

42分钟前

​锡业股份:上半年净利润10.62亿元,同比增长32.76%

36氪获悉,锡业股份披露2025年半年报,上半年实现营业收入210.93亿元,同比增长12.35%;归属于上市公司股东的净利润10.62亿元,同比增长32.76%;基本每股收益0.626元。

42分钟前

亚世光电:上半年净利润538.04万元,同比下降36.21%

36氪获悉,亚世光电披露2025年半年报,上半年实现营业收入4.32亿元,同比增长30.01%;归属于上市公司股东的净利润538.04万元,同比下降36.21%;基本每股收益0.0331元。

42分钟前

金螳螂:上半年净利润3.58亿元,同比增长3.95%

36氪获悉,金螳螂披露2025年半年报,上半年实现营业收入95.28亿元,同比增长2.49%;归属于上市公司股东的净利润3.58亿元,同比增长3.95%;基本每股收益0.1348元。

42分钟前

本页详细列出关于儿宝健的品牌信息,含品牌所属公司介绍,儿宝健所处行业的品牌地位及优势。
咨询